Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1038 of 1,261
  1. US 7511018

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  2. US 7511032

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  3. US 7511124

    Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  4. US 7511015

    Modified defensins and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  5. US 7510710

    Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor

    The Regents of the University of Colorado · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  6. US 7511053

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  7. US 7510726

    Methods and compositions for deterring abuse of opioid containing dosage forms

    Acurx Pharmaceuticals, Inc. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  8. US 7510715

    Protozoan derived compositions and methods of use thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  9. US 7511038

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  10. US 7511095

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics AL, Corporation · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  11. US 7510728

    Solid preparations

    Takeda Pharmaceutical Company Limited · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  12. US 7507841

    Cannabinoid receptor modulator

    Takeda Pharmaceutical Company Limited · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  13. US 7507716

    Method for treating pain with prolactin antagonists

    The Board of Regents of the University of Texas System · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  14. US 7507740

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  15. US 7507753

    Biaryl compound and use thereof

    Takeda Chemical Industries Ltd. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  16. US 7507829

    Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  17. US 7507809

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  18. US 7507861

    Process for the preparation of atomoxetine hydrochloride

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  19. US 7507407

    Immunoliposomes that optimize internationalization into target cells

    The Regents of the University of California · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  20. US 7507422

    Urinary tract tissue graft compositions and methods for producing same

    The Board of Regents of the University of Oklahoma · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  21. US 7507556

    Nucleic acids encoding rat hyaluronan receptor for endocytosis

    The Board of Regents of the University of Oklahoma · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  22. US 7507751

    Biphenyl derivatives

    Theravance, Inc. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  23. US 7507538

    Human papilloma virus immunoreactive peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  24. US 7507826

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.